Moderate to severe acne vulgaris in female patients Inflammatory acne vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female volunteers aged between 25 and 35 years. 2. Diagnosed with moderate to severe inflammatory acne based on the IAA grading of acne severity, with at least 10 to 20 inflammatory lesions. 3. Willingness to participate and provide informed consent.
Exclusion criteria
Exclusion criteria: 1. Participants who are pregnant or breastfeeding. 2. Participants with underlying medical conditions that affect acne, such as adrenal tumor or polycystic ovary syndrome. 3. Participants with medical conditions that contraindicate the use of copper bromide laser, such as systemic lupus erythematosus (SLE) or photosensitivity. 4. Participants who are currently taking medications that may affect acne, such as systemic steroids, oral contraceptives, or hormone replacement therapy. 5. Participants who have changes in their acne treatment regimen during the study period, including: 5.1 Participants taking oral acne medications must have been on a stable regimen for at least 2 months prior to enrollment. 5.2 Participants using topical acne treatments must have been using them consistently for at least 6 weeks before the study. 5.3 Participants undergoing acne procedures must have received them consistently for at least 1 month before joining the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne count 3 months Counting , photograph | — |
Secondary
| Measure | Time frame |
|---|---|
| Sebum production 3 months Sebumeter,Porphyrin 3 months Visia | — |
Countries
Thailand
Contacts
Dhurakij Pundit university